Encompass Health revenue and financials
$122.76Change from previous close: −1.55%Absolute change: −$1.93
In the fiscal year ended December 2025, Encompass Health reported revenue of $5.94B (+10.46% year over year). Net income was $566.2M, a net margin of 9.5%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +10.46%
- 2025 vs 2024
- Net income growth
- +24.25%
- 2025 vs 2024
- Net margin
- 9.5%
- 2024: 8.5%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 283 | 313 | 346 | 271 | 270 | 289 | 279 | 268 | 217 | 239 | 201 | 215 |
| Depreciation and amortization | 90.4 | 87.3 | 86.4 | 82.4 | 79.9 | 79.2 | 78.0 | 78.4 | 72.9 | 70.3 | 70.1 | 67.3 |
| Capital expenditure | -220 | -162 | -229 | -187 | -157 | -163 | -199 | -148 | -157 | -139 | -212 | -150 |
| Investing cash flow | -236 | -150 | -239 | -201 | -165 | -159 | -204 | -162 | -158 | -130 | -208 | -162 |
| Financing cash flow | -76.9 | -103 | -97.4 | -113 | -90.2 | -130 | -151 | -89.5 | -49.6 | -40.6 | -29.9 | -65.8 |
| Dividends paid | -18.9 | -20.3 | -19.0 | -17.0 | -17.1 | -18.0 | -17.0 | -15.0 | -14.9 | -15.9 | -14.9 | -15.0 |
| Share repurchases | -74.2 | -103 | -76.4 | -24.9 | -24.8 | -51.9 | -7.5 | -6.8 | -16.8 | -12.1 | -0.1 | -0.4 |
| Debt issued | 750 | 420 | 70.0 | 80.0 | 0.0 | 60.0 | 30.0 | 15.0 | — | 50.0 | — | — |
| Debt repaid | -695 | -330 | -28.1 | -109 | -22.3 | -80.0 | -117 | -157 | -13.1 | -50.0 | -6.1 | -27.0 |
| Net change in cash | -29.9 | 60.5 | 9.2 | -43.7 | 14.6 | -0.3 | -75.8 | 16.8 | 9.4 | 68.5 | -37.0 | -12.8 |
| Free cash flow | 62.3 | 151 | 117 | 83.7 | 113 | 126 | 80.1 | 120 | 60.5 | 99.4 | -10.7 | 65.5 |
| Levered free cash flow | 32.0 | 60.8 | 100.0 | 37.2 | 86.1 | 73.5 | 48.9 | 52.8 | 60.7 | 53.5 | -63.4 | -2.2 |